Native and γ radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium

Atherosclerosis

Volumn 132, Issue 1, 1997, Pages 29-35

  Beaudeux, Jean Louis ^a   Césarini, Marie Luce ^b   Gardès Albert, Monique ^c   Maclouf, Jacques ^b   Merval, Régine ^b   Esposito, Bruno ^b   Peynet, Jacqueline ^a   Tedgui, Alain ^b  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c CNRS   (France)

Author keywords

Cell adhesion; Endothelium; Monocytes; Oxidized lipoprotein(a); Oxidized low density lipoprotein

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; AORTA MEDIA; ARTERY INTIMA; ARTICLE; BLOOD CLOT LYSIS; CELL ADHESION; DISULFIDE BOND; ENDOTHELIUM CELL; FOAM CELL; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RADIOLYSIS; RAT;

ANIMALS; AORTA, THORACIC; ARTERIOSCLEROSIS; CELL ADHESION; DINOPROST; ENDOTHELIUM, VASCULAR; FREE RADICALS; GAMMA RAYS; LIPID PEROXIDATION; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MONOCYTES; OXIDATION-REDUCTION; RABBITS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR CELLS, CULTURED;

EID: 17144472802     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00073-7     Document Type: Article

References (58)

1. Scanu AM, Fless GM. Lipoprotein(a): Heterogeneity and biological relevance. J Clin Invest 1990;85:1709-15.
2. Fless GM, Rolih CA, Scanu AM. Heterogeneity of human plasma lipoprotein(a). J Biol Chem 1984;259:11470-8.
3. Utermann G. The mysteries of lipoprotein(a). Science 1989;246:904-10.
4. McLean JW, Tomlinson JE, Kuang W, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
5. Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller C, Lawn RM, Scanu AM. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987;84:3224-8.
6. Howard GC, Pizzo SV. Biology of disease: Lipoprotein(a) and its role in atherothrombotic disease. Lab Invest 1993;69:373-86.
7. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantitation of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989;9:579-92.
8. Jamieson DG, Usher DC, Rader DJ, Lavi E. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Am J Pathol 1995;147:1567-74.
9. Hajjar KA, Nachman RL. The role of lipoprotein(a) in atherogenesis and thrombosis. Annual Rev Med 1996;47:423-42.
10. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocytes/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-8.
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320:915-24.
12. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990;87:904-8.
13. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996;20:707-27.
14. Naruszewicz M, Selinger E, Davignon J. Oxidative modification of lipoprotein(a) and the effect of β-carotene. Metab Clin Exp 1992;41:1215-24.
15. Sattler W, Kostner GM, Waeg G, Esterbauer H. Oxidation of lipoprotein(a). A comparison with low-density lipoproteins. Biochim Biophys Acta 1991;1081:65-74.
16. Beaudeux JL, Gardes-Albert M, Delattre J, Legrand A, Rousselet F, Peynet J. Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by y radiolysis: A comparison with low-density lipoprotein. Biochem J 1996;314:277-84.
17. O'Connell AM, Gieseg SP, Stanley KK. Hypochlorite oxidation causes cross-linking of Lp(a). Biochim Biophys Acta 1994;1225:180-6.
18. Naruszewicz M, Giroux LM, Davignon J. Oxidative modification of lipoprotein(a) causes changes in the structure and biological properties of apo(a). Chem Phys Lipids 1994;67/68:167-74.
19. de Rijke YB, Jurgens G, Hessels EMAJ, Hermann A, van Berkel TJC. In vivo fate and scavenger receptor recognition of oxidized lipoprotein(a) isoforms in rats. J Lipid Res 1992;33:1315-25.
20. Galle J, Bengen J, Schollmeyer P, Wanner C. Oxidized lipoprotein(a) inhibits endothelium-dependent dilatation: Prevention by high density lipoprotein. Eur J Pharmacol 1994;265:111-5.
21. Gopaul NK, Nourooz-Zadeh J, Mallet AI, Anggard EE. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem Biophys Res Comms 1994;200:338-43.
22. Morrow JD, Roberts 2nd LJ. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996;51:1-9.
23. Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 1991;49:1063-74.
24. Snyder ML, Polacek D, Scanu AM, Fless GM. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. J Biol Chem 1992;267:339-46.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
26. Prior WA, Castle L. Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol 1984;105:293-9.
27. Yagi K. A simple fluorimetric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
28. Wang Z, Ciabattoni G, Creminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2a excretion in man. J Pharm Exp Ther 1995;275:94-100.
29. Teale FWJ. The ultraviolet fluorescence of proteins in neutral solutions. Biochem J 1960;76:381-8.
30. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-82.
31. DiCortelo PE, de la Motte CA. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J Clin Invest 1985;75:1153-61.
32. Bedwell S, Dean RT, Jessup W. The action of oxygen-centred free radicals on human low-density lipoprotein. Biochem J 1989;262:707-12.
33. 2 free radicals produced by y radiolysis. Radiation Res 1993;134:271-82.
34. Mehta Yang B, Khan S, Hendricks JB, Stephen C, Mehta JL. Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation. Arterioscler Thromb Vasc Biol 1995;15:2076-83.
35. Pritchard KA, Tota RR, Lin JHC, Danishefsky KJ, Kurilla BA, Holland JA, Stermerman MB. Native low density lipoprotein: endothelial recruitment of mononuclear cells. Arterioscler Thromb 1991;11:1175-81.
36. Frostegard J, Haegerstrand A, Gidlund M, Nilsson J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 1991;90:119-26.
37. Jeng JR, Chang CH, Shieh SM, Chiu HC. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim Biophys Acta 1993;1178:221-7.
38. Lehr HA, Seemuller J, Hubner C, Menger MD, Messmer K. Oxidized LDL induced leukocyte-endothelium interaction in vivo involves the receptor for platelet-activating factor. Arterioscler Thromb 1993;13:1013-8.
39. Lehr HA, Krober M, Hubner C, Vajkoczy P, Menger MD, Nolte D, Kohlschutter A, Messmer K. Stimulation of leukocyte/ endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 1993;68:388-95.
40. Pritchard KA, Wang PY, Stemerman MB. Atherogenic concentration of low-density lipoprotein enhances endothelial cell generation of epoxyeicosatrienoic acid products. Am J Pathol 1990;136:1381-91.
41. Weber C, Erl W, Weber PC. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD 11b. Biochem Biophys Res Comm 1995;206:621-8.
42. Ragab MS, Selvaraj P, Sgoutas DS. Oxidized lipoprotein(a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. Atherosclerosis 1996;123:103-13.
43. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-44.
44. Smalley DM, Lin JHC, Curtis ML, Kobari Y, Stemerman MB, Pritchard KA. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arterioscler Thromb Vase Biol 1996;16:585-90.
45. Cominacini L, Garbin U, Fratta Pasini A, Davoli A, Campagnola M, Contessi GB, Pastorino AM, Lo Cascio V. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Rad Biol Med 1997;22:117-27.
46. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994;71:380-6.
47. Gebuhrer V, Murphy JF, Bordet JC, Reck MP, McGregor JL. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem J 1995;306:293-8.
48. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988;8:851-7.
49. Dudani AK, Ganz PR. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol 1996;95:168-78.
50. Krempler F, Kostner GM, Roscher A, Haslauer F, Bolzano K, Sandhofer F. Studies on the role of specific cell surface receptors in the removal of lipoprotein(a) in man. J Clin Invest 1983;71:1431-41.
51. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989;339:301-3.
52. Diamond MS, Stauton DE, de Fougerolles AR, Stacker SA, Carcia-Aguilar J, Hibbs ML, Springer TA. ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990;111:3129-35.
53. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, Smith CW, Haberland ME, Fogelman AM, Berliner JA. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb 1994;14:427-33.
54. Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Circ Res 1996;78:780-7.
55. Lynch SM, Morrow JD, Roberts LJ, Frei B. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low-density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994;93:998-1004.
56. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res 1995;77:335-41.
57. Banerjee M, Kang KH, Morrow JD, Roberts LJ, Newman JH. Effects of a novel prostaglandin, 8-epi-PGF2α, in rabbit lung in situ. Am J Physiol 1992;263:H660-3.
58. Morrow JD, Minton TA, Roberts LJ. The F2-isoprostane, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endo-peroxide receptor antagonist. Prostaglandins 1992;44:155-63.